Advances in non and minimal-invasive transcutaneous delivery of immunotherapy for cancer treatment

• Main Authors: Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Qui Thanh Hoai Ta, Van Giau Vo
• Format: Article
• Language: English
• Published: Elsevier 2020-11-01
• Series: Biomedicine & Pharmacotherapy
• Subjects: Transcutaneous; Non and minimal-invasive; Cancer; Immunotherapy; Drug; Inflammation
• Online Access: http://www.sciencedirect.com/science/article/pii/S075333222030946X

Cancer research has focused on figuring out what was the difference between cancer cells and the tissues within which cancer arose and developing targeted treatments for those differences. With FDA-approved treatments for more ten different cancers and more than thousand new clinical trials, immunotherapy has recently emerged as the most promising area of cancer research by improving efficacy and controlling the adverse effects. Transcutaneous delivery drug delivery offers a number of advantages for the patient because of not only its noninvasive and convenient nature but also factors such as avoidance of first-pass metabolism and prevention of gastrointestinal degradation. The purpose of this review was to highlight technological recent approaches to non and minimal-invasive delivery of immunotherapy for cancer treatment. Finally, some practical considerations and discussions for future studies in the field of transdermal immunomodulation are also included.